Subscribe to Blog via Email
It was a little bit foggy, wet, windy and very cold and that was at the bottom of the hill we were looking up at. It wasn’t a terribly big hill, but I knew it would need considerable effort and some temporary pain. Whilst the rain splashed onto our jackets and the wind howled, Chris and I looked at each other and we simultaneously said, “do we really want to go up that in this weather?” Oh yes ……. no pain, no gain! So, we went up the hill and it hurt. Up there, it was wetter, windier and much colder! However, the ‘euphoric high’ was worth it. It was like medicine healing the mind.
The ‘euphoric high’ is kicking in!
Whatever your ‘hill’ is, two of the common elements required to ‘climb it’ are motivation and willpower. However, if you’re fighting cancer and you’re being affected by the symptoms or the side effects of treatment, it can be easy to opt to stay within your ‘comfort zone’ even though you know the ‘hill‘ might do you some good. I suspect this is a common predicament for a cancer patient, do I ‘climb that hill’ or do I walk away? Sure, I walk away from the “hill” occasionally, but I try not to make a habit of it.
My personal hill metaphor is actually a hill but yours can be something else as described above. Just do something hard!
Go and climb that hill!
Top 10 Posts & Pages in the last 48 hours (auto updates) (Click the titles to read them)
Thanks for reading.
Sign up for my newsletters – Click Here
Check out my Glossary of Terms – click here
Please Share this post for Neuroendocrine Cancer awareness and to help another patient
What is Satoreotide? It’s an agonist treatment. i.e. a ‘next generation’ radiologand for Peptide receptor radionuclide therapy (PRRT) or more specifically the radiopharmaceutical that binds
On my website RonnyAllan.NET, September was an interesting month because I had pushed out some blogs before I went on a planned overseas holiday from
There has been controversy about the utility of Chromogranin A for many years now. Specialists have been critical about its use but to be fair
UPDATE – Sep 25th, 2023 – Novartis radioligand therapy Lutathera® demonstrated statistically significant and clinically meaningful progression-free survival in first line advanced gastroenteropancreatic neuroendocrine tumors
Whenever I get a chance to talk to a pharma involved in somatostatin analogue injection devices, I tell them one very important thing …… “To
A cup of tea
I would also mention those who contributed to my “Tea Fund” which resides on PayPal. You don’t need a PayPal account as you can select a card but don’t forget to select the number of units first (i.e. 1 = £4, 2 = £8, 3 = £12, and so on), plus further on, tick a button to NOT create a PayPal account if you don’t need one. Clearly, if you have a PayPal account, the process is much simpler
Through your generosity, I am able to keep my sites running and provide various services for you. I have some ideas for 2023 but they are not detailed enough to make announcements yet.
This screenshot is from every single post on my website and depending on which machine you are using, it will either be top right of the post or at the bottom (my posts are often long, so scroll down!)